160 likes | 361 Views
Procedure for narcotic drugs use for medical purposes in the Republic of Kazakhstan. Current legislative system of the RK (summary) Prescription procedure and drug delivery Consumption statistics (International data).
E N D
Procedure fornarcotic drugs use for medical purposes in the Republic of Kazakhstan
Current legislative system of the RK (summary) • Prescription procedure and drug delivery • Consumption statistics (International data)
General description of the current legislative system of the Republic of Kazakhstan
Prescription procedure and delivery of drugs, containingnarcotic, psychotropic substances and precursors in the Republic of Kazakhstan Resolution of the Government of the RK No 396 dated 30 March 2012 On adoption of regulations for medical use of the narcotic, psychotropic substances and precursors which are subject to control in the Republic of Kazakhstan
Prescription blank • Drugs containing narcotic, psychotropic substances and precursors included in the List are prescribed on the special prescription pink format A6 blank printed typographically with the code, blank number and protection level. Code includes an administrative-territorial unit identification number of the Republic of Kazakhstan
Signature • “individuals taking drugs containing narcotic, psychotropic substances for therapeutic purposes must have the document confirming the legality of these drugs purchase. Form of this document is to be established by authorized health body” as agreed by the Committee. This document is named a “signature”
Signature • Name of the pharmaceutical organization ________________________________________________________________________ • CODE ________________________________ Prescription No. ________________, Prescription date____________________ • Name of the pharmaceutical organization ________________________________________________________________________ • Rp: _________________________________________________________________________________________________ • ____________________________________________________________________________________________________ • ____________________________________________________________________________________________________ • ____________________________________________________________________________________________________ • Mode of administration • Physician’s full name________________________________________________________ • Prepared by________________________________________________________ • Checked by ________________________________________________________ • Released by ________________________________________________________ • Date _______________________________________________________________
Narcotic substance containing drug storage and inventory procedure
Maximum allowance for narcotic substance containing drug prescription and release
Western Asia: Average opioid consumption 1997-1999, 2007-2009